Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of DWP-450 for moderate-to-severe glabellar lines
2014-001063-12Phase 3Completed
- Sponsor
- Evolus, Inc.
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Evolus, Inc.. Started Mar 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2014-001063-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001063-12.